Keynotes

Get inspired by leaders in the field from around the world during each of the keynote lectures featured throughout ACC.25. Each individual has been selected based on their outstanding contributions to the field of cardiovascular medicine. 56th Annual Louis F. Bishop Keynote Session 202. Artificial Intelligence Intensive I: The Machines Are Coming! Basics of Clinical Augmented Intelligence for the Practicing Clinician Saturday, March 29, 11:30 a.m. – 12:30 p.m. Past, Present and Future of Clinical AI in

Read the full article here

Source: accscientificsession.acc.org

Categories: Cardiologists, General Medicine News

Tags: ACC25

Tweets with this article

American College of Cardiology

Get inspired by 🌎 leaders in CV medicine at #ACC25! 🎬 Explore, learn, & gain insights from keynote speakers 👇 recognized for their exceptional contributions to the field. https://t.co/74tu8OMrxi @DrJRums @Bweber04 @kofi_larry https://t.co/XewLUzb8YM

Related Articles

How the brain impacts the heart: lessons from ischaemic stroke and other neurological disorders

Cardiovascular alterations are common in patients who had ischaemic stroke, haemorrhagic stroke and other acute brain disorders such as seizures. These cardiac complications are important…

Heart_BMJ February 5, 2025

Home – Arrhythmia Alliance

A-A is a coalition of charities, patient groups, patients, carers, medical groups and allied professionals. A-A provides support, information, education, and awareness to all those…

AF Association February 5, 2025

The U.S.’s exit from WHO, a chance to reshape global health

Global health should not be at the mercy of funding or the expertise from one or a handful of high-income countries and must be a…

Giuseppe Biondi-Zoccai February 5, 2025

COVID-19-causing virus linked to coronary plaque progression, risk for MI, death

SARS-CoV-2 infection was associated with more rapid coronary plaque progression and significantly increased risk for adverse outcomes related to target lesion failure, such as heart…

Cardiology Today February 5, 2025

FDA clears first assay designed to measure lipoprotein(a) in nanomoles

Roche announced its next generation assay received FDA 510(k) clearance for the measurement of lipoprotein(a) for assessment of CV risk. The assay (Tina-quant Gen.2) is…

Cardiology Today February 5, 2025

Let it heal!

The purpose of this case report is to discuss the treatment of a chronic total occlusion (CTO) in a 58-year-old male patient with multiple cardiovascular…

Salvatore Brugaletta February 5, 2025

The Myocardial Ischaemia National Audit Project (MINAP)

AbstractAims. The Myocardial Ischaemia National Audit Project (MINAP) collects data from admissions in England, Wales, and Northern Ireland with Type 1 myo

Prof Chris P Gale February 5, 2025

Besplatna HPV vakcina za sve do 26 godina!

Zašto HPV vakcina treba da postane besplatna za sve mlade do 26 godina. Humani papiloma virus (HPV) predstavlja jedan od vodećih uzroka raka grlića materice,…

Biljana Parapid, MD, PhD, FESC February 5, 2025

Secondary Prevention Medications in 17 Countries Grouped by Income Level (PURE): A Prospective Cohort Study

AbstractBackgroundIt is unclear whether global use of medications for secondary cardiovascular (CVD) prevention is improving over time.ObjectivesThis study across 17 high-, middle- and low-income c…

Harlan Krumholz February 5, 2025

TAV-in-SAV for surgical bioprosthetic valve failure

Explore the key considerations for TAV-in-SAV procedures for failed surgical bioprosthetic valves, including how to avoid high gradients and patient-prosthesis mismatch, and the clinical relevance…

PCRonline February 5, 2025